Page last updated: 2024-09-05

ly 300502 and epristeride

ly 300502 has been researched along with epristeride in 4 studies

Compound Research Comparison

Studies
(ly 300502)
Trials
(ly 300502)
Recent Studies (post-2010)
(ly 300502)
Studies
(epristeride)
Trials
(epristeride)
Recent Studies (post-2010) (epristeride)
6004744

Protein Interaction Comparison

ProteinTaxonomyly 300502 (IC50)epristeride (IC50)
3-oxo-5-alpha-steroid 4-dehydrogenase 1Homo sapiens (human)3.4
3-oxo-5-alpha-steroid 4-dehydrogenase 1 Rattus norvegicus (Norway rat)0.0475
3-oxo-5-alpha-steroid 4-dehydrogenase 2Homo sapiens (human)0.0053
3-oxo-5-alpha-steroid 4-dehydrogenase 2Rattus norvegicus (Norway rat)0.05

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakshi, RK; Chang, B; Ellsworth, K; Harris, GS; Mosley, RT; Patel, GF; Rasmusson, GH; Tolman, RL1
Baginsky, WF; Bakshi, RK; Bull, H; Chang, B; Cimis, G; Ellsworth, K; Harris, GS; Patel, GF; Rasmusson, GH; Tolman, RL1
Audia, JE; Hirsch, KS; Jones, CD; Lawhorn, DE; McQuaid, LA; Neubauer, BL; Pennington, PA; Pike, AJ; Stamm, NB; Toomey, RE1
Ballard, S; Blagg, J; Fox, D; Kenny, B1

Reviews

1 review(s) available for ly 300502 and epristeride

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997

Other Studies

3 other study(ies) available for ly 300502 and epristeride

ArticleYear
4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.
    Journal of medicinal chemistry, 1995, Aug-18, Volume: 38, Issue:17

    Topics: 5-alpha Reductase Inhibitors; Androstenes; Azasteroids; Humans; Molecular Conformation; Thermodynamics

1995
4,7 beta-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5 alpha-reductase.
    Journal of medicinal chemistry, 1994, Nov-11, Volume: 37, Issue:23

    Topics: 5-alpha Reductase Inhibitors; Azasteroids; Humans

1994
Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase.
    Journal of medicinal chemistry, 1993, Feb-05, Volume: 36, Issue:3

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Cell Line; Humans; Male; Quinolones; Structure-Activity Relationship

1993